Capital Flow Monitor · Sponsors · CIK 1689694
K Health, Inc.
387 Park Avenue South, 9th Floor, NEW YORK, NY, 10016 · 646-844-7859
Other Technology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$68.9M
Sold
$58.9M
% sold
85.5%
Investors
19
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-19 | D ·current | 506(b) | $68.9M | $58.9M | 85.5% | 19 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Allon Bloch — Executive Officer / Director, NEW YORK, NY
- Adam Singolda — Director, NEW YORK, NY
- Mark Tluszcz — Director, NEW YORK, NY
- Alejandro Zubillaga — Director, NEW YORK, NY
-
Vivek Pattipati — Director, NEW YORK, NY
3 other raises
- Crusoe Inc. $3.11B of $3.9B · 79.7%
- Silicon Derivatives Inc. $30.5M of $35.0M · 87.1%
- DroneBase, Inc. $130.0M of $130.0M · 100.0%
- Saad Ehtisham — Director, NEW YORK, NY
- Vivian Riefberg — Director, NEW YORK, NY
- Niyum Gandhi — Director, NEW YORK, NY
- C. Okey Agba — Director, NEW YORK, NY
- Nir Zohar — Director, NEW YORK, NY
- Chen Yehudai — Executive Officer, NEW YORK, NY
- Yaron Savoray — Executive Officer, NEW YORK, NY
- Ran Shaul — Executive Officer, NEW YORK, NY
- Zac Siegel — Executive Officer, NEW YORK, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.